Injection Oxytocin vs Injection Carbetocin in reduction of postpartum blood loss in caesarean section

Inj.Oxytocin vs Inj.Carbetocin in reduction of postpartum blood loss in caesarean section- a randomized control study.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054091

Enrollment

146

Registered

2023-06-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O721- Other immediate postpartum hemorrhage

Interventions

Intervention1: Administration of inj carbetocin: drug to prevent excessive blood loss after caesarean delivery Control Intervention1: administration of Inj Oxytocin: drugs to prevent excessive post pa

Eligibility

Inclusion criteria

Inclusion criteria: 1.Multiple pregnancy 2.Previous LSCS 3.Fibroids or Previous h/o Myomectomy 4.GDM 5.Previous history of PPH 6.Fetal macrosomia 7.Polyhydramnios 8.Hypertension and its disorders in pregnancy 9.Informed consent

Exclusion criteria

Exclusion criteria: 1.Patients not willing to take part in the study 2.H/O Hypersensitivity to carbetocin 3.k/c/o epilepsy 4.Placenta Accreta spectrum

Design outcomes

Primary

Measure	Time frame
To find out effectiveness of inj oxytocin vs inj carbetocin in reducing post partum blood loss in caesarean deliveriesTimepoint: 28 weeks POG	—

Secondary

Measure	Time frame
To evaluate the EFFICACY OF CARBETOCIN VS OXYTOCIN on Additional use of uterotonic drugs Timepoint: 28 weeks- 42 weeks	—

Countries

India

Contacts

Public ContactGeethika Vegesna

Jawaharlal Nehru Medical college, Belagavi

yvpujar@hotmail.com9448142989

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026